These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26088116)

  • 61. Effects of the ornidazole enantiomers on the central nervous system: Involvement of the GABAA receptor.
    Wei TT; Sun JH; Han LW; Chen K; Wang ZQ; Ji H
    Chem Biol Interact; 2015 Dec; 242():163-9. PubMed ID: 26415617
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story.
    Jones EA
    Hepatology; 1991 Dec; 14(6):1286-90. PubMed ID: 1660022
    [No Abstract]   [Full Text] [Related]  

  • 63. Effects of GABA(A) compounds on mCPP drug discrimination in rats.
    Gatch MB; Jung ME; Wallis CJ; Lal H
    Life Sci; 2002 Oct; 71(22):2657-65. PubMed ID: 12354584
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study.
    Potokar J; Coupland N; Glue P; Groves S; Malizia A; Bailey J; Wilson S; Nutt D
    Alcohol Alcohol; 1997; 32(5):605-11. PubMed ID: 9373703
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient.
    Krystal AD; Watts BV; Weiner RD; Moore S; Steffens DC; Lindahl V
    J ECT; 1998 Mar; 14(1):5-14. PubMed ID: 9661088
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Flumazenil-independent positive modulation of gamma-aminobutyric acid action by 6-methylflavone at human recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptors.
    Hall BJ; Chebib M; Hanrahan JR; Johnston GA
    Eur J Pharmacol; 2004 Apr; 491(1):1-8. PubMed ID: 15102527
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.
    Mandema JW; Kuck MT; Danhof M
    Br J Pharmacol; 1992 Jan; 105(1):164-70. PubMed ID: 1350744
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15-4513 in the rat CNS.
    Mehta AK; Shank RP
    Brain Res; 1995 Dec; 704(2):289-97. PubMed ID: 8788925
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist.
    Brogden RN; Goa KL
    Drugs; 1991 Dec; 42(6):1061-89. PubMed ID: 1724638
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pharmacology of the GABA receptor functions in the central nervous systems].
    Fukuda H; Ito Y
    Yakugaku Zasshi; 1998 Sep; 118(9):339-52. PubMed ID: 9778998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Augmentation of GABAA receptor function by chronic exposure to GABA-neutral and GABA-negative benzodiazepine ligands in cultured cortical neurons.
    Miller LG; Heller J; Lumpkin M; Weill CL; Greenblatt DJ; Shader RI
    Biochem Pharmacol; 1990 Sep; 40(6):1337-44. PubMed ID: 2169744
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Contrasting regulation by GABA of the displacement of benzodiazepine antagonist binding by benzodiazepine agonists and purines.
    Skerritt JH; Davies LP; Chow SC; Johnston GA
    Neurosci Lett; 1982 Oct; 32(2):169-74. PubMed ID: 6128704
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Flumazenil: a new benzodiazepine antagonist.
    Votey SR; Bosse GM; Bayer MJ; Hoffman JR
    Ann Emerg Med; 1991 Feb; 20(2):181-8. PubMed ID: 1996802
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A benzodiazepine antagonist flumazenil in clinical use--a dose finding study].
    Hanaoka K; Yamamura H; Numata K; Okada K; Amaha K; Kobayashi K; Nagano M; Yogosawa T
    Masui; 1990 Sep; 39(9):1092-100. PubMed ID: 2246798
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2.
    Knoflach F; Benke D; Wang Y; Scheurer L; Lüddens H; Hamilton BJ; Carter DB; Mohler H; Benson JA
    Mol Pharmacol; 1996 Nov; 50(5):1253-61. PubMed ID: 8913357
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Osmotic shock: a method to eliminate endogenous gamma-aminobutyric acid and account for the influence on benzodiazepine binding affinity in autoradiographic studies.
    McCabe RT; Olsen RW; Yezuita JP; Wamsley JK
    J Pharmacol Exp Ther; 1988 Apr; 245(1):342-9. PubMed ID: 2834541
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The use of antidotes in the management of central nervous system depression.
    Ferrer A; Civeira E; Lopez P; Loren B
    Arch Toxicol Suppl; 1997; 19():289-98. PubMed ID: 9079215
    [No Abstract]   [Full Text] [Related]  

  • 80. Neuropharmacological potentials of β-carboline alkaloids for neuropsychiatric disorders.
    Ayipo YO; Mordi MN; Mustapha M; Damodaran T
    Eur J Pharmacol; 2021 Feb; 893():173837. PubMed ID: 33359647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.